Search

everythinglearnresearchcommunity

for

Search:↓

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

A horse in Brazil with skin and gut issues was diagnosed with a severe disease and had to be euthanized.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

A rare case of a woman having both lichen planus pigmentosus and classic lichen planopilaris at the same time.

The new gel for psoriasis is effective, stable, and easy to apply.

A child with a rare scalp condition regrew hair after treatment.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

New effective scar treatments are urgently needed due to the current options' limited success.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

Liposomes could improve how skin care products work but are costly and not very stable.

Microneedling is promising for treating various skin issues but needs more research to confirm its effectiveness and safety.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.